Bionano Genomics, Inc. Increase (Decrease) in Accounts Payable
Bionano Genomics, Inc. (BNGO) reported Increase (Decrease) in Accounts Payable of -$1.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-10
- Bionano Genomics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$500.00K.
- Bionano Genomics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$528.00K.
- Bionano Genomics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$399.00K.
- Bionano Genomics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$254.00K.
- Bionano Genomics, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$1.37M.
- Bionano Genomics, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$3.42M.
- Bionano Genomics, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$2.00M, a 202.36% decline from fiscal 2022.
- Bionano Genomics, Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.95M, a 71.26% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.03M 10-Q · filed 2026-08-10 | -$1.43M derived: sum of 3 quarters · filed 2026-08-10 | -$1.68M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$528.00K 10-Q · filed 2026-05-13 | -$927.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.18M derived: sum of 3 quarters · filed 2026-05-13 | -$1.50M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$653.00K derived: sum of 2 quarters · filed 2026-03-23 | -$971.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.37M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | -$254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$572.00K derived: sum of 2 quarters · filed 2026-08-10 | -$973.00K 10-Q · filed 2025-11-13 | -$2.71M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$719.00K 10-Q · filed 2026-08-10 | -$2.46M derived: sum of 3 quarters · filed 2026-08-10 | -$2.49M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$401.00K 10-Q · filed 2026-05-13 | -$2.14M derived: sum of 2 quarters · filed 2026-05-13 | -$2.17M derived: sum of 3 quarters · filed 2026-05-13 | -$3.28M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$1.77M derived: sum of 2 quarters · filed 2026-03-23 | -$2.88M derived: sum of 3 quarters · filed 2026-03-23 | -$3.42M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.14M derived: sum of 2 quarters · filed 2025-11-13 | -$1.68M 10-Q · filed 2025-11-13 | -$6.08M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.65M 10-Q · filed 2025-08-14 | -$6.04M derived: sum of 3 quarters · filed 2025-08-14 | -$2.85M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$537.00K 10-Q · filed 2025-05-14 | -$4.93M derived: sum of 2 quarters · filed 2025-05-14 | -$1.74M derived: sum of 3 quarters · filed 2025-05-14 | -$5.55M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.20M derived: sum of 2 quarters · filed 2025-03-31 | -$5.01M derived: sum of 3 quarters · filed 2025-03-31 | -$2.00M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$616.00K derived: sum of 2 quarters · filed 2024-11-14 | $2.40M 10-Q · filed 2024-11-14 | $5.58M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$3.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$791.00K 10-Q · filed 2024-08-07 | $2.39M derived: sum of 3 quarters · filed 2024-08-07 | $3.23M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $3.02M 10-Q · filed 2024-05-08 | $6.20M derived: sum of 2 quarters · filed 2024-05-08 | $7.04M derived: sum of 3 quarters · filed 2024-05-08 | $8.13M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $4.02M derived: sum of 2 quarters · filed 2024-03-05 | $5.12M derived: sum of 3 quarters · filed 2024-03-05 | $1.95M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.94M derived: sum of 2 quarters · filed 2023-11-08 | -$1.23M 10-Q · filed 2023-11-08 | $603.00K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.07M 10-Q · filed 2023-08-09 | -$2.07M 10-Q · filed 2022-08-04 | -$237.00K derived: sum of 3 quarters · filed 2023-08-09 | $3.89M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$3.17M 10-Q · filed 2023-05-09 | -$1.33M derived: sum of 2 quarters · filed 2023-05-09 | $2.80M derived: sum of 3 quarters · filed 2023-05-09 | $4.66M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $5.96M derived: sum of 2 quarters · filed 2023-03-09 | $7.83M derived: sum of 3 quarters · filed 2023-03-09 | $6.78M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.99M derived: sum of 2 quarters · filed 2022-11-03 | $4.95M 10-Q · filed 2022-11-03 | $2.21M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $816.00K 10-Q · filed 2022-08-04 | -$1.92M derived: sum of 3 quarters · filed 2022-08-04 | -$1.14M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$1.04M 10-Q · filed 2022-05-05 | -$3.78M derived: sum of 2 quarters · filed 2022-05-05 | -$3.00M derived: sum of 3 quarters · filed 2022-05-05 | -$3.33M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.96M derived: sum of 2 quarters · filed 2022-03-01 | -$2.29M derived: sum of 3 quarters · filed 2022-03-01 | -$1.81M 10-K · filed 2022-03-01 | -$1.81M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $448.00K derived: sum of 2 quarters · filed 2021-11-04 | $925.00K 10-Q · filed 2021-11-04 | $1.25M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $150.00K 10-Q · filed 2021-08-04 | $470.40K derived: sum of 3 quarters · filed 2021-08-04 | -$744.60K derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $477.00K 10-Q · filed 2021-05-13 | $797.40K derived: sum of 2 quarters · filed 2021-05-13 | -$417.60K derived: sum of 3 quarters · filed 2021-05-13 | $2.35M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $320.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$894.60K derived: sum of 2 quarters · filed 2021-03-23 | $1.87M derived: sum of 3 quarters · filed 2021-03-23 | $1.36M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.55M derived: sum of 2 quarters · filed 2020-11-13 | $1.04M 10-Q · filed 2020-11-13 | $1.04M 10-Q · filed 2019-11-07 | $26.84K derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $2.26M 10-Q · filed 2020-08-13 | $2.26M 10-Q · filed 2019-08-08 | $1.24M derived: sum of 3 quarters · filed 2020-08-13 | $2.36M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$511.00K 10-Q · filed 2020-06-18 | -$510.55K 10-Q · filed 2019-05-09 | -$1.53M derived: sum of 2 quarters · filed 2020-06-18 | -$406.99K derived: sum of 3 quarters · filed 2020-06-18 | -$109.81K derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $104.01K derived: sum of 2 quarters · filed 2020-03-10 | $401.19K derived: sum of 3 quarters · filed 2020-03-10 | -$954.38K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.42M derived: sum of 2 quarters · filed 2019-11-07 | $60.79K 10-Q · filed 2019-11-07 | $1.28M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $297.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$1.06M 10-Q · filed 2019-08-08 | $162.90K derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2018-03-31 | -$1.36M 10-Q · filed 2019-05-09 | -$134.28K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.54M 10-K · filed 2019-03-14 | ||||||
| 2017-09-30 | $320.18K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |